Javascript must be enabled to continue!
Evaluating Performance of Drug Repurposing Technologies
View through CrossRef
Abstract
Drug repurposing technologies are growing in number and maturing. However, comparison to each other and to reality is hindered due to lack of consensus with respect to performance evaluation. Such comparability is necessary to determine scientific merit and to ensure that only meaningful predictions from repurposing technologies carry through to further validation and eventual patient use. Here, we review and compare performance evaluation measures for these technologies using version 2 of our shotgun repurposing Computational Analysis of Novel Drug Opportunities (CANDO) platform to illustrate their benefits, drawbacks, and limitations. Understanding and using different performance evaluation metrics ensures robust cross platform comparability, enabling us to continuously strive towards optimal repurposing by decreasing time and cost of drug discovery and development.
Title: Evaluating Performance of Drug Repurposing Technologies
Description:
Abstract
Drug repurposing technologies are growing in number and maturing.
However, comparison to each other and to reality is hindered due to lack of consensus with respect to performance evaluation.
Such comparability is necessary to determine scientific merit and to ensure that only meaningful predictions from repurposing technologies carry through to further validation and eventual patient use.
Here, we review and compare performance evaluation measures for these technologies using version 2 of our shotgun repurposing Computational Analysis of Novel Drug Opportunities (CANDO) platform to illustrate their benefits, drawbacks, and limitations.
Understanding and using different performance evaluation metrics ensures robust cross platform comparability, enabling us to continuously strive towards optimal repurposing by decreasing time and cost of drug discovery and development.
Related Results
Multiscale virtual screening optimization for shotgun drug repurposing using the CANDO platform
Multiscale virtual screening optimization for shotgun drug repurposing using the CANDO platform
Abstract
Drug repurposing, the practice of utilizing existing drugs for novel clinical indications, has tremendous potential for improving human health outcomes and...
Network-based Drug Repurposing: A Critical Review
Network-based Drug Repurposing: A Critical Review
Abstract:
New drug development for a disease is a tedious, time-consuming, complex, and expensive
process. Even if it is done, the chances for success of newly developed drugs are ...
Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Drug repositioning or repurposing is a revolutionary breakthrough in drug development
that focuses on rediscovering new uses for old therapeutic agents. Drug repositioning can be
d...
Validating DTAPs with large language models: A novel approach to drug repurposing
Validating DTAPs with large language models: A novel approach to drug repurposing
In the face of escalating costs and lengthy timelines associated with traditional drug discovery, our study introduces a novel approach aimed at enhancing the drug repurposing proc...
Potential drug–drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia
Potential drug–drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia
Background: Concomitant use of several drugs for a patient is often imposing increased risk of drug–drug interactions. Drug–drug interactions are a major cause for concern in patie...
Artificial Intelligence in Clinical Practice: Unlocking New Horizons in Drug Repurposing for Disease Treatment
Artificial Intelligence in Clinical Practice: Unlocking New Horizons in Drug Repurposing for Disease Treatment
Artificial intelligence (AI) has emerged as a transformative force in drug repurposing, offering innovative solutions to expedite the identification of new therapeutic uses for exi...
Proteomics and Drug Repurposing in CLL towards Precision Medicine
Proteomics and Drug Repurposing in CLL towards Precision Medicine
CLL is a hematological malignancy considered as the most frequent lymphoproliferative disease in the western world. It is characterized by high molecular heterogeneity and despite ...
AI in drug repurposing for cancer therapies
AI in drug repurposing for cancer therapies
Artificial intelligence (AI) is transforming drug discovery by enabling the rapid identification of existing drugs with potential anti-cancer properties, a process known as drug re...

